Rafferty Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $490K | Sell |
37,646
-11,837
| -24% | -$154K | ﹤0.01% | 895 |
|
|
2025
Q1 | $524K | Sell |
49,483
-8,109
| -14% | -$85.9K | ﹤0.01% | 854 |
|
|
2024
Q4 | $977K | Sell |
57,592
-7,628
| -12% | -$129K | ﹤0.01% | 798 |
|
|
2024
Q3 | $1.51M | Sell |
65,220
-12,794
| -16% | -$297K | 0.01% | 706 |
|
|
2024
Q2 | $1.9M | Sell |
78,014
-78,579
| -50% | -$1.91M | 0.01% | 656 |
|
|
2024
Q1 | $5.29M | Buy |
156,593
+43,421
| +38% | +$1.47M | 0.02% | 465 |
|
|
2023
Q4 | $3.57M | Sell |
113,172
-19,609
| -15% | -$618K | 0.02% | 514 |
|
|
2023
Q3 | $3.39M | Sell |
132,781
-25,704
| -16% | -$657K | 0.02% | 476 |
|
|
2023
Q2 | $4.55M | Sell |
158,485
-47,989
| -23% | -$1.38M | 0.03% | 438 |
|
|
2023
Q1 | $4.95M | Sell |
206,474
-2,780
| -1% | -$66.6K | 0.03% | 387 |
|
|
2022
Q4 | $3.55M | Sell |
209,254
-51,726
| -20% | -$877K | 0.03% | 451 |
|
|
2022
Q3 | $3.87M | Buy |
260,980
+60,794
| +30% | +$901K | 0.04% | 377 |
|
|
2022
Q2 | $3.15M | Sell |
200,186
-102,004
| -34% | -$1.61M | 0.03% | 378 |
|
|
2022
Q1 | $8.15M | Buy |
302,190
+81,784
| +37% | +$2.2M | 0.05% | 224 |
|
|
2021
Q4 | $8.16M | Buy |
220,406
+61,523
| +39% | +$2.28M | 0.04% | 233 |
|
|
2021
Q3 | $7.59M | Sell |
158,883
-27,946
| -15% | -$1.34M | 0.05% | 216 |
|
|
2021
Q2 | $6.32M | Buy |
186,829
+119,483
| +177% | +$4.04M | 0.04% | 267 |
|
|
2021
Q1 | $2.78M | Buy |
67,346
+58,551
| +666% | +$2.42M | 0.02% | 537 |
|
|
2020
Q4 | $382K | Sell |
8,795
-42,609
| -83% | -$1.85M | ﹤0.01% | 747 |
|
|
2020
Q3 | $2.21M | Buy |
+51,404
| New | +$2.21M | 0.03% | 384 |
|